Federico Innocenti - Researcher Profile

Publications

2 shown

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Hedy L. Kindler , Donna Niedzwiecki , Donna Hollis +12 more

Purpose The combination of gemcitabine plus bevacizumab produced a 21% response rate and a median survival of 8.8 months in a multicenter phase II trial in patients with metasta...

2010 Journal of Clinical Oncology 834 citations

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

Akram Yazdani , Heinz‐Josef Lenz , Gianluigi Pillonetto +20 more

2025 UNC Libraries 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 834
Institution: Cancer Research Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9247-979X

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.